Which Treatment Is Effective for Bruxism: Occlusal Splints or Botulinum Toxin?
[PURPOSE] The aim of the present study was to compare the efficacy of an occlusal splint and botulinum toxin for the treatment of bruxism.
- p-value P < .0001
APA
Yurttutan ME, Tütüncüler Sancak K, Tüzüner AM (2019). Which Treatment Is Effective for Bruxism: Occlusal Splints or Botulinum Toxin?. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 77(12), 2431-2438. https://doi.org/10.1016/j.joms.2019.06.005
MLA
Yurttutan ME, et al.. "Which Treatment Is Effective for Bruxism: Occlusal Splints or Botulinum Toxin?." Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, vol. 77, no. 12, 2019, pp. 2431-2438.
PMID
31302066
Abstract
[PURPOSE] The aim of the present study was to compare the efficacy of an occlusal splint and botulinum toxin for the treatment of bruxism.
[PATIENTS AND METHODS] Seventy-three patients with myofascial pain due to bruxism were included in the present study. The patients were allocated into 3 groups. Group A was treated with an occlusal splint, group B was treated with botulinum toxin injections, and group C was treated with an occlusal splint and botulinum toxin injections. The Temporomandibular Disorder Pain Screener, Graded Chronic Pain Scale, Oral Behavior Checklist, Jaw Function Limitation Scale, and visual analog scale (VAS) by palpation of the chewing muscles were administered to all patients before treatment and 6 months after treatment.
[RESULTS] The questionnaire and VAS scores decreased in all 3 groups (P < .0001). The VAS and questionnaire scores had decreased significantly in groups B and C compared with those in group A (mean VAS score: group A, 5 [range, 3 to 7]; group B, 1.9 ± 0.97; group C, 1.79 [range, 0 to 3]).
[CONCLUSIONS] Occlusal splints might not be necessary for patients treated with botulinum toxin injections.
[PATIENTS AND METHODS] Seventy-three patients with myofascial pain due to bruxism were included in the present study. The patients were allocated into 3 groups. Group A was treated with an occlusal splint, group B was treated with botulinum toxin injections, and group C was treated with an occlusal splint and botulinum toxin injections. The Temporomandibular Disorder Pain Screener, Graded Chronic Pain Scale, Oral Behavior Checklist, Jaw Function Limitation Scale, and visual analog scale (VAS) by palpation of the chewing muscles were administered to all patients before treatment and 6 months after treatment.
[RESULTS] The questionnaire and VAS scores decreased in all 3 groups (P < .0001). The VAS and questionnaire scores had decreased significantly in groups B and C compared with those in group A (mean VAS score: group A, 5 [range, 3 to 7]; group B, 1.9 ± 0.97; group C, 1.79 [range, 0 to 3]).
[CONCLUSIONS] Occlusal splints might not be necessary for patients treated with botulinum toxin injections.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 5 |
MeSH Terms
Botulinum Toxins; Bruxism; Humans; Mastication; Occlusal Splints; Pain Measurement; Splints; Treatment Outcome
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.